SEMEDLAB: Three Spanish Associations Unite to Advance Laboratory Medicine
On Jan. 1, the Spanish Society of Laboratory Medicine (SEMEDLAB) was formally established in Madrid, marking the merger of three longstanding organizations: the Spanish Association of Medical Biopathology-Laboratory Medicine (AEBM-ML), the Spanish Association of Clinical Laboratory (AEFA), and the Spanish Society of Laboratory Medicine (SEQCML). This unification brings together decades of expertise and innovation in the field.
“This isn’t a completely new start,” explains Antonio Buño, the newly appointed president. “The oldest of these societies has 76 years of history, and the youngest is 48 years old. They’ve been well-established national entities, and over the years, we’ve seen increasing overlap in their activities. In fact, the National Congress has been a joint effort for the past 18 years, and many members belonged to two or even all three societies. Our goals aligned—confirmed by member surveys—and the timing felt right.”
The process of merging began in early 2024, with a working group led by the presidents of the three societies. Legal experts guided the complex process, as mergers of this nature are rare. “We didn’t start from scratch; we had nearly 4,000 members and built on the strengths of each group. Now, we aim to do more, improve efficiency, and redefine our structures. The response has been overwhelmingly positive, and while this is a transitional year, we’re focused on stabilizing this change with generosity, enthusiasm, and hard work.”
Choosing a name and logo for the new society sparked significant discussion. “We wanted something representative and a domain that was available,” Buño notes. “Branding experts helped us, and we’ve landed on a logo that everyone is starting to embrace.”
### A Cornerstone of Modern Medicine
Buño emphasizes that laboratory medicine is “a discipline without which modern medicine cannot be understood. We play a vital role across all specialties.” Innovations like new biomarkers and liquid biopsies are revolutionizing diagnostics and personalized treatments, enabling the analysis of tailored marker profiles.
Data management is another critical area, with artificial intelligence taking center stage. “AI’s predictive capabilities are transforming decision-making, giving rise to what’s now called the digital biomarker,” Buño explains. Image recognition, supported by AI algorithms, is also expanding the laboratory’s capabilities. “We’re highly dependent on technology, acting as translators between patients’ needs and clinical demands,” he adds.
Point-of-care testing, which allows for decentralized care, has also gained momentum, particularly since the pandemic, enabling rapid pathology screenings at the patient’s bedside.
### Inspiring New Voices
One of SEMEDLAB’s key goals is to attract new talent to the field. “Laboratory medicine remains one of the least popular specialties among medical residents,” Buño acknowledges. “While it’s easy to blame this on a lack of awareness, the reality is that most medical schools don’t teach clinical laboratory work or clinical biochemistry as core subjects.”
He believes greater exposure could spark interest. “Students often tell us they didn’t understand how laboratories actually function. For me, laboratory medicine encompasses one of the most beautiful aspects of medicine: understanding the pathophysiology of diseases. It’s about diagnosing not just what’s wrong, but why, and seeing the impact of treatments on patients. In some cases, this can even lead to direct patient interaction.”
With its rich history, innovative vision, and commitment to nurturing future professionals, SEMEDLAB is poised to shape the future of laboratory medicine in Spain and beyond.
Overwhelmingly positive, with a shared vision of advancing laboratory medicine in Spain and beyond,” says Buño.
The establishment of SEMEDLAB represents a historic milestone in the field of laboratory medicine, uniting the collective expertise, resources, and vision of three influential societies under one umbrella. This merger is not just a consolidation of organizations but a strategic move to foster innovation, streamline efforts, and amplify the impact of laboratory professionals on healthcare outcomes. By leveraging their combined strengths, SEMEDLAB is poised to lead advancements in research, education, and clinical practice, ensuring that laboratory medicine remains at the forefront of medical innovation.
As SEMEDLAB embarks on this new chapter, it carries forward the legacy of its predecessors while embracing the opportunities of the future. The society is committed to addressing the evolving challenges of healthcare, promoting interdisciplinary collaboration, and advocating for the critical role of laboratory professionals in patient care. With a foundation built on decades of excellence and a unified mission, SEMEDLAB is well-positioned to shape the future of laboratory medicine, not onyl in Spain but on the global stage. This merger is a testament to the power of unity and shared purpose, heralding a brighter, more impactful era for the field.
The establishment of the Spanish Society of Laboratory Medicine (SEMEDLAB) on January 1 marks a historic milestone in the evolution of laboratory medicine in Spain. By uniting the Spanish Association of Medical Biopathology-Laboratory Medicine (AEBM-ML), the Spanish Association of Clinical Laboratory (AEFA), and the Spanish Society of Laboratory Medicine (SEQCML), SEMEDLAB brings together a rich legacy of expertise, innovation, and collaboration. This merger not only consolidates decades of progress but also positions the field to meet the challenges and opportunities of modern medicine with renewed vigor.
As antonio Buño,the newly appointed president,highlights,this unification is not a break from the past but a natural progression driven by shared goals and member support. The formation of SEMEDLAB reflects a forward-thinking approach, leveraging the strengths of its predecessors to enhance efficiency, redefine structures, and amplify the impact of laboratory medicine on healthcare.
Laboratory medicine is undeniably a cornerstone of modern healthcare, enabling advancements in diagnostics, personalized treatments, and data-driven decision-making through innovations like biomarkers, liquid biopsies, and artificial intelligence. SEMEDLAB’s commitment to fostering these advancements underscores its vital role in bridging the gap between patient needs and clinical demands.
Moreover, SEMEDLAB’s efforts to inspire the next generation of professionals are crucial for the continued growth and relevance of the field. By addressing the challenges of attracting new talent and embracing emerging technologies, SEMEDLAB is poised to shape the future of laboratory medicine in Spain and beyond.
As SEMEDLAB embarks on this transformative journey, it carries the collective achievements of its founding societies while embracing a mission to innovate, collaborate, and lead. with a spirit of generosity, enthusiasm, and dedication, SEMEDLAB stands as a beacon of progress, ensuring that laboratory medicine remains at the forefront of healthcare innovation for years to come.